You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy

Article metrics

Article menu
XML
Oncolytic and local immunotherapy
Original research
Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy

 

Online download statistics by month:

Online download statistics by month: October 2020 to December 2025

AbstractFullPdf
Oct 2020562562274
Nov 2020323323150
Dec 2020145145101
Jan 2021200200115
Feb 202112212274
Mar 202114314391
Apr 202110810881
May 202110810865
Jun 2021848469
Jul 2021828268
Aug 202111511563
Sep 2021565664
Oct 2021122122111
Nov 2021979686
Dec 2021595934
Jan 2022949628
Feb 2022777938
Mar 2022859047
Apr 2022828644
May 2022959855
Jun 2022818242
Jul 2022808827
Aug 2022869436
Sep 2022666974
Oct 2022798750
Nov 2022676728
Dec 2022495023
Jan 2023747434
Feb 2023838434
Mar 2023869045
Apr 2023393925
May 2023565625
Jun 2023808139
Jul 2023494920
Aug 2023424221
Sep 2023303115
Oct 2023686829
Nov 202310510526
Dec 202310110133
Jan 2024566055
Feb 2024737767
Mar 20246060137
Apr 2024626248
May 2024727636
Jun 2024818838
Jul 2024545519
Aug 20244749166
Sep 2024404024
Oct 20245152103
Nov 2024585937
Dec 2024646527
Jan 2025646434
Feb 2025686832
Mar 2025474925
Apr 202511111151
May 2025565744
Jun 2025454546
Dec 2025100
Total519052683273